ACCESSION: MSBNK-SMB_Measured-HSA015P0115003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 49
COMMENT: RAW_SPEC {'EL03_pos_2728': {'bp': 3205157.0, 'sum': 6436832.0}, 'EL01_pos_2530': {'bp': 1394967.0, 'sum': 3166487.0}, 'EL10_pos_2530': {'bp': 1495478.0, 'sum': 3310629.0}, 'EL06_pos_2325': {'bp': 1836176.0, 'sum': 4009287.0}, 'EL02_pos_2524': {'bp': 1845153.0, 'sum': 3984235.0}, 'EL07_pos_2531': {'bp': 1516252.0, 'sum': 3373056.0}, 'EL19_pos_2548': {'bp': 1754633.0, 'sum': 3931478.0}, 'EL02_pos_2327': {'bp': 1799553.0, 'sum': 3864870.0}, 'EL07_pos_2326': {'bp': 1706449.0, 'sum': 3511049.0}, 'EL19_pos_2333': {'bp': 1767878.0, 'sum': 3773946.0}, 'EL17_pos_2315': {'bp': 1724827.0, 'sum': 3673218.0}, 'EL17_pos_2524': {'bp': 1649658.0, 'sum': 3723196.0}, 'EL06_pos_2531': {'bp': 1589373.0, 'sum': 3530441.0}, 'EL22_pos_2536': {'bp': 1804182.0, 'sum': 3975359.0}, 'EL05_pos_2327': {'bp': 1759428.0, 'sum': 3851822.0}, 'EL22_pos_2333': {'bp': 1868973.0, 'sum': 4007804.0}, 'EL23_pos_2321': {'bp': 1633539.0, 'sum': 3480682.0}, 'EL14_pos_2518': {'bp': 1484511.0, 'sum': 3376664.0}, 'EL11_pos_2505': {'bp': 1455651.0, 'sum': 3223834.0}, 'EL21_pos_2518': {'bp': 1704951.0, 'sum': 3632155.0}, 'EL23_pos_2535': {'bp': 1624412.0, 'sum': 3547618.0}, 'EL20_pos_2518': {'bp': 1593763.0, 'sum': 3533384.0}, 'EL16_pos_2507': {'bp': 1483835.0, 'sum': 3324223.0}, 'EL12_pos_2321': {'bp': 1795631.0, 'sum': 3751453.0}, 'EL12_pos_2507': {'bp': 1697017.0, 'sum': 3612261.0}, 'EL09_pos_2325': {'bp': 1684027.0, 'sum': 3558972.0}, 'EL15_pos_2507': {'bp': 1589463.0, 'sum': 3566629.0}, 'EL24_pos_2339': {'bp': 1505626.0, 'sum': 3282910.0}, 'EL01_pos_2331': {'bp': 1469420.0, 'sum': 3240965.0}, 'EL15_pos_2327': {'bp': 1811443.0, 'sum': 3750158.0}, 'EL21_pos_2315': {'bp': 1741215.0, 'sum': 3700678.0}, 'EL20_pos_2314': {'bp': 1740680.0, 'sum': 3512090.0}, 'EL23_pos_2381': {'bp': 1713550.0, 'sum': 3524560.0}, 'EL05_pos_2530': {'bp': 1742222.0, 'sum': 3845467.0}, 'EL10_pos_2332': {'bp': 1648949.0, 'sum': 3439665.0}, 'EL16_pos_2372': {'bp': 1621558.0, 'sum': 3414905.0}, 'EL04_pos_2555': {'bp': 1493817.0, 'sum': 3241845.0}, 'EL11_pos_2326': {'bp': 1691209.0, 'sum': 3556483.0}, 'EL13_pos_2524': {'bp': 1650374.0, 'sum': 3543653.0}, 'EL18_pos_2332': {'bp': 1605047.0, 'sum': 3456311.0}, 'EL24_pos_2578': {'bp': 1552565.0, 'sum': 3439517.0}, 'EL08_pos_2331': {'bp': 1532459.0, 'sum': 3447621.0}, 'EL18_pos_2530': {'bp': 1481237.0, 'sum': 3357784.0}, 'EL13_pos_2327': {'bp': 1674922.0, 'sum': 3556744.0}, 'EL04_pos_2332': {'bp': 1580445.0, 'sum': 3417756.0}, 'EL09_pos_2505': {'bp': 1625986.0, 'sum': 3607514.0}, 'EL16_pos_2314': {'bp': 1556608.0, 'sum': 3440799.0}, 'EL14_pos_2332': {'bp': 1577368.0, 'sum': 3426386.0}, 'EL08_pos_2531': {'bp': 1574988.0, 'sum': 3426970.0}}
COMMENT: RETENTION_TIME_STDEV 0.173
COMMENT: PRECURSOR_M/Z_RAW 115.123352
COMMENT: PRECURSOR_M/Z_STDEV 0.000039
COMMENT: PRECURSOR_IN_MS1 mz 115.122946; int 54.324; delta(ppm) 0.662748
COMMENT: PROPOSED_CHARGE_STATE +1; mz 116.126315; int 3.515; cor 0.747
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.228; C6H14N2; [M+H]+; delta(ppm) -0.227839
COMMENT: PROPOSED_MF MS-FINDER 2.983; C6H14N2; [M+H]+; delta(ppm) -0.233605
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.314; C6H14N2; [M+H]+; delta(ppm) -0.233605
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H14N2; [M+H]+; delta(ppm) -0.233605
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.558; WGCYRFWNGRMRJA-UHFFFAOYSA-N; [M+H]+; CCN1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.461; SVXZTUWVVQGRPC-UHFFFAOYNA-N; [M+H]+; CC(CCN)N1CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.404; RXYPXQSKLGGKOL-UHFFFAOYSA-N; [M+H]+; CN1CCN(C)CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.404; VKIRRGRTJUUZHS-UHFFFAOYSA-N; [M+H]+; C1CC(CCC1N)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.340; DBMHTLOVZSDLFD-UHFFFAOYSA-N; [M+H]+; C1CCN(CC1)CN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.679; RXYPXQSKLGGKOL-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.627; SSJXIUAHEKJCMH-UHFFFAOYNA-N; [M+H]+; cyclohexane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.575; WGCYRFWNGRMRJA-UHFFFAOYSA-N; [M+H]+; 1-ethylpiperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; RHPBLLCTOLJFPH-UHFFFAOYNA-N; [M+H]+; piperidine-2-methylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; SVXZTUWVVQGRPC-UHFFFAOYNA-N; [M+H]+; ??-methylaziridine-1-propylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; DBMHTLOVZSDLFD-UHFFFAOYSA-N; [M+H]+; piperidin-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; NSMWYRLQHIXVAP-OLQVQODUSA-N; [M+H]+; (2R,5S)-2,5-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; VKIRRGRTJUUZHS-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,4-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.523; YMHQVDAATAEZLO-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SVXZTUWVVQGRPC-UHFFFAOYNA-N; [M+H]+; ??-methylaziridine-1-propylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.854; RXYPXQSKLGGKOL-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.854; WGCYRFWNGRMRJA-UHFFFAOYSA-N; [M+H]+; 1-ethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.838; RHPBLLCTOLJFPH-UHFFFAOYNA-N; [M+H]+; piperidine-2-methylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.838; DBMHTLOVZSDLFD-UHFFFAOYSA-N; [M+H]+; piperidin-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.824; SSJXIUAHEKJCMH-UHFFFAOYNA-N; [M+H]+; cyclohexane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.824; NSMWYRLQHIXVAP-OLQVQODUSA-N; [M+H]+; (2R,5S)-2,5-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.824; VKIRRGRTJUUZHS-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.824; YMHQVDAATAEZLO-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.781; SSJXIUAHEKJCMH-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.986; RXYPXQSKLGGKOL-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.979; VKIRRGRTJUUZHS-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.522; GEQHKFFSPGPGLN-UHFFFAOYSA-N; [M+H]+; cyclohexane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.442; NSMWYRLQHIXVAP-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.438; WGCYRFWNGRMRJA-UHFFFAOYSA-N; [M+H]+; 1-ethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.364; LHQRDAIAWDPZGH-UHFFFAOYSA-N; [M+H]+; cyclohexylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; QXDVFQAKOKIPCM-ONEGZZNKSA-N; [M+H]+; (E)-N,N'-dimethylbut-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.295; WRXNJTBODVGDRY-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.288; SRGQQZYVZFJYHJ-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.284; ARHYWWAJZDAYDJ-UHFFFAOYSA-N; [M+H]+; 1,2-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.232; IFNWESYYDINUHV-UHFFFAOYSA-N; [M+H]+; 2,6-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.218; UGBKOURNNQREPE-UHFFFAOYSA-N; [M+H]+; azepan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.209; LTEKQAPRXFBRNN-UHFFFAOYSA-N; [M+H]+; piperidin-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; CZGIEJXGCLWRPY-UHFFFAOYSA-N; [M+H]+; N,1-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; GOLVGZOPWLLUSF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; LPXOXONOLFNMPX-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1-methylazetidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; VCGBXNXXMFHOBK-UHFFFAOYSA-N; [M+H]+; (1-ethylazetidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; JUFKJRCMBLLXNH-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrolidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; BAOBZCAXECCBQL-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrolidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; XZSXCKGIKBUXEN-UHFFFAOYSA-N; [M+H]+; hexanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; OCITTXIQCCPLRK-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-N,N-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; BOGOVRPYKWYEKM-UHFFFAOYSA-N; [M+H]+; N'-cyclopropyl-N'-methylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; XFAJTOGPBDJOTQ-UHFFFAOYSA-N; [M+H]+; 1-propylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; YGSQGWLRGUDBKG-UHFFFAOYSA-N; [M+H]+; 2-(1-methylazetidin-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; QQNQTARUSRGFQV-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-N-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; YKGDAMWMFVRGDH-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.115; APRDXQSALZYCME-UHFFFAOYSA-N; [M+H]+; (3-methylpyrrolidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.115; SVXZTUWVVQGRPC-UHFFFAOYSA-N; [M+H]+; 3-(aziridin-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; JRZFLGYOIRLVTR-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; FXHRAKUEZPSMLJ-UHFFFAOYSA-N; [M+H]+; 1-methyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; ALOCUZOKRULSAA-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; AVAWMINJNRAQFS-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.020; IGCVAKMLNISJHR-UHFFFAOYSA-N; [M+H]+; N-methylpiperidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; JJTPAWVDTZOKNB-UHFFFAOYSA-N; [M+H]+; cyclopentylmethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; IKMMUVYSVDIQEB-UHFFFAOYSA-N; [M+H]+; (3-methylcyclopentyl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; DCPLDPXQOOHYSU-UHFFFAOYSA-N; [M+H]+; 1,3-dimethyl-1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; RHPBLLCTOLJFPH-UHFFFAOYSA-N; [M+H]+; piperidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; FHTGZDVYPCEHFQ-UHFFFAOYSA-N; [M+H]+; N-methylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; DXOHZOPKNFZZAD-UHFFFAOYSA-N; [M+H]+; 2-ethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; OPCPWFHLFKAUEA-UHFFFAOYSA-N; [M+H]+; N-ethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; RXSIKRLQGANXCL-UHFFFAOYSA-N; [M+H]+; N,N-diethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; FMMUNDXXVADKHS-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.976; QZSACHHNFDNCNB-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; IPOVLZSJBYKHHU-UHFFFAOYSA-N; [M+H]+; piperidin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; PIPWSBOFSUJCCO-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; MCULVESJRLLZOP-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-2-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; LJAXTAOSOVPBQH-UHFFFAOYSA-N; [M+H]+; N-methylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; WJUBYASTGWKFHK-UHFFFAOYSA-N; [M+H]+; azepan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; RPMVELKOENZIBB-UHFFFAOYSA-N; [M+H]+; 1,2-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; HFRAIQDUWJODKF-UHFFFAOYSA-N; [M+H]+; N-methyl-1-pyrrolidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; MSHQGNNZIQLBHV-UHFFFAOYSA-N; [M+H]+; 1-(azetidin-3-yl)-N,N-dimethylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; KAEAOSROYJPPIZ-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; ZUGCXQDQYRDQTR-UHFFFAOYSA-N; [M+H]+; N,N,3-trimethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; YFZGXSSOURPKGL-UHFFFAOYSA-N; [M+H]+; 3-(azetidin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; QWUYUMSIOXRISF-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; CTCROLHSTQLQKI-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; TYRJTKUUMOUABY-UHFFFAOYSA-N; [M+H]+; N-ethyl-1-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; UCDCTEVWRISNRB-UHFFFAOYSA-N; [M+H]+; 1-(azetidin-2-yl)-N,N-dimethylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; KXIDLVNTUQFPDA-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; VRSIHZAGCZQYOU-WDSKDSINSA-N; [M+H]+; (2S,3S)-2-methylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; RGCMVVXOZMQXJQ-UHFFFAOYSA-N; [M+H]+; hex-5-ene-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; COWPTMLRSANSMQ-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; ZBLACDIKXKCJGF-UHFFFAOYSA-N; [M+H]+; [2-(aminomethyl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; QLNNMIUPRPKARZ-UHFFFAOYSA-N; [M+H]+; N'-cyclopentylmethanediamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; KMRLPKVQSAHVSQ-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; PQOHPULQDOKUOG-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; JNMHKIHUTNBSJN-UHFFFAOYSA-N; [M+H]+; 1-N,1-N-dimethylcyclobutane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; LJGMFMZLKFEDGU-UHFFFAOYSA-N; [M+H]+; N'-(cyclopropylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; XJRPIZCHFSKXPJ-UHFFFAOYSA-N; [M+H]+; N'-cyclopropyl-N-methylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; ROVFTSSCUXGEQX-UHFFFAOYSA-N; [M+H]+; 1-[(dimethylamino)methyl]cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; PCSCFJLGJHWKJL-ZCFIWIBFSA-N; [M+H]+; (5R)-5-methyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; MTPQNWBLEVTLSZ-NTSWFWBYSA-N; [M+H]+; (1R,2S)-2-[(dimethylamino)methyl]cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; WOVCKCWRYAHUDR-PHDIDXHHSA-N; [M+H]+; (1R,2R)-2-N,2-N-dimethylcyclobutane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; NORUUYRXMOOAHX-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; LCCOGJXPFJFMPR-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylbutanimidamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H15N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.923
MS$FOCUSED_ION: PRECURSOR_M/Z 115.122948
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-7900000000-e1ffa98f91359cef8ba8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388421 5.1849 53.039540 1.3009 1.29 -0.1629 39 f{C4H5}/5.01ppm,p-C2H10N2
  55.0180724 12.9385 55.018780 0.9088 2.32 -0.2332 49 ?
  55.0545222 23.2531 55.055230 0.7084 3.02 -0.2860 49 f{C4H7}/5.37ppm,p-C2H8N2
  67.0543685 18.3899 67.055110 0.9544 2.60 -0.0355 49 f{C5H7}/2.12ppm,p-C1H8N2
  68.0496326 19.9831 68.050375 1.0287 2.94 0.3964 48 f{C4H6N1}/2.31ppm,p-C2H9N1
  69.0336120 6.2461 69.034355 1.2603 1.65 -0.0190 36 ?
  69.0700170 135.4621 69.070760 0.2896 8.17 -0.4140 49 f{C5H9}/2.03ppm,p-C1H6N2
  70.0652767 31.8244 70.066020 0.6708 14.91 -0.6654 49 f{C4H8N1}/2.16ppm,p-C2H7N1
  70.0733567 7.2795 70.074100 1.3415 1.55 -0.1382 43 ?
  71.0492418 9.5134 71.049985 1.1682 2.25 -0.0726 46 ?
  71.0856168 10.9612 71.086360 0.9425 2.09 -0.1190 49 f{C5H11}/1.27ppm,p-C1H4N2
  72.0808871 16.5001 72.081630 1.0405 2.96 0.3236 47 f{C4H10N1}/1.55ppm,p-C2H5N1
  72.9372476 111.2243 72.937990 0.3839 49.82 0.7680 49 ?
  73.0468977 25.3308 73.047640 0.9720 6.74 0.7155 48 ?
  74.9376397 14.7155 74.938380 1.0942 7.97 0.7123 40 ?
  79.0543078 183.1162 79.055040 0.3162 11.10 -0.3278 49 f{C6H7}/1.03ppm,p-H8N2
  80.0576305 11.3892 80.058360 0.9368 2.31 -0.1270 43 ?
  80.9451332 43.1611 80.945860 0.7289 33.59 -0.7310 49 ?
  86.0964634 14.7118 86.097170 0.9873 2.38 -0.1098 49 f{C5H12N1}/0.44ppm,p-C1H3N1
  88.0757032 7.8005 88.076400 1.3965 1.88 -0.0194 44 ?
  90.9476796 14.4610 90.948360 1.2865 6.68 0.8041 47 ?
  91.0574303 18.4027 91.058110 1.1092 5.32 0.7335 49 ?
  96.0807851 113.6099 96.081430 0.3226 8.28 0.1447 49 f{C6H10N1}/0.10ppm,p-H5N1
  97.0648028 40.6208 97.065440 0.6594 4.17 -0.3242 49 ?
  97.0841529 7.3309 97.084790 1.3287 1.40 -0.0734 41 ?
  114.0913790 999.0000 114.091870 0.2629 0.00 -0.2575 49 ?
  115.0947573 68.2040 115.095240 0.5648 3.90 -0.2499 49 ?
  115.1229875 30.9657 115.123470 1.0250 22.16 1.0000 47 f{C6H15N2}/0.11ppm,p
  116.9661432 36.2041 116.966610 1.0003 28.53 -0.6739 49 ?
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  53.038842 5.18 5
  55.018072 12.94 12
  55.054522 23.25 23
  67.054368 18.39 18
  68.049633 19.98 19
  69.033612 6.25 6
  69.070017 135.46 135
  70.065277 31.82 31
  70.073357 7.28 7
  71.049242 9.51 9
  71.085617 10.96 10
  72.080887 16.50 16
  72.937248 111.22 111
  73.046898 25.33 25
  74.937640 14.72 14
  79.054308 183.12 183
  80.057631 11.39 11
  80.945133 43.16 43
  86.096463 14.71 14
  88.075703 7.80 7
  90.947680 14.46 14
  91.057430 18.40 18
  96.080785 113.61 113
  97.064803 40.62 40
  97.084153 7.33 7
  114.091379 999.00 999
  115.094757 68.20 68
  115.122988 30.97 30
  116.966143 36.20 36
//
